Introduction
Prescription errors occur in all healthcare settings and all healthcare professionals are encouraged to reduce prescribing errors to optimise patient safety and reduce the consequences of such errors. Studies from the USA suggest that at least one error per prescription occurs in up to 1.9% of all prescriptions and is estimated to cause harm in up to 1% of all inpatient episodes. 1 Potential fatal prescribing errors may occur in up to 1-2% of all prescriptions. 2 The literature on paediatric prescribing has addressed medical prescribing and pharmacological dispensing errors and interventions by pharmacists or clinicians to reduce prescribing errors. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Prescribing for children is more complicated than that for adults because of their different ages, weights and metabolism of drugs. This may be partly accounted for by prescriptions based on body weight or body surface area. A recent study of outpatient paediatric prescriptions suggested that 15% of children were dispensed medications with a potential dosing error 5 ; errors were more frequent when the child's weight was <35 kg with incorrect doses identified in up to 32% of prescriptions. 5 In contrast, another study of inpatient prescriptions found that the most common error was incomplete clinical or demographic information, with an overall error rate of 19.1%.
two AEDs to achieve seizure control. Finally, all AEDs may be associated with significant adverse side effects. To demonstrate the complexity of AED prescribing one study looked at AEDs and changes between outpatient prescription and medication received in ambulatory care at a later date. There were frequent and significant changes in medications and brands administered over time. 12 This paper evaluates all new prescriptions of AEDs issued within the outpatient department of a large children's hospital; to the best of our knowledge it is the largest study that has reported AED prescription in children. The paper focuses on the completeness and accuracy of the prescriptions and need for pharmacist intervention before the AED could be dispensed and within the context of prescribing errors in children.
Methods
The study was a retrospective and observational study of all new prescriptions for an AED issued from the general paediatric and paediatric neurology outpatient departments over a 12 month period (1st January 2012 to 31st December 2012). Repeat prescriptions for an AED that children were already receiving were excluded. All outpatient prescriptions in this institution (a large children's hospital) are completed in writing using a single side and in-triplicate, A4 proforma.
All outpatient prescriptions are processed and medications dispensed from the hospital's single pharmacy department. It is likely that all relevant prescriptions were identified for evaluation during the study period primarily because all new outpatient prescriptions are processed from this hospital's only outpatient pharmacy department.
Prescriptions were evaluated for the following information: patient demographics, diagnosis/indication for the AED, medication details including clarity of instructions for dose regimes, prescriber details and whether pharmacist intervention was required to clarify or alter medication details and before the medication could be dispensed. Data were collected on whether the prescription was written by a consultant or a trainee but not whether it was written by a member of the paediatric or paediatric neurology team.
The epilepsy nurse specialists in our institution do not prescribe AEDs.
All statistical analysis of data was performed using 'Microsoft Excel'.
Ethical approval was not required as this was a survey (audit). However, the study was carried out in accordance with the guidelines of the Declaration of Helsinki for medical research. All data reported were anonymised.
Results

Prescription completion
Two hundred and sixty two new prescriptions were evaluated for 243 patients; 19 patients received more than one new prescription. Seventy three (27.9%) prescriptions were complete; 72.1% were incomplete with at least one piece of missing information.
Diagnosis recorded
One hundred and sixty four (62.6%) of all prescriptions did not state any diagnosis or indication for the prescribed medication. Of the remaining 98, 50 cited only the single word, 'Epilepsy' and 48 cited a non-epileptic diagnosis -'Migraine', 'Behavioural problems' and 'Chronic pain'. 
Prescriber details
Pharmacy intervention
Prescribers were contacted by a pharmacist in 44 prescriptions (16.8%). Fifteen of the 44 prescriptions (34%) were due to an error in dose or frequency of administration and the remaining 29 were for other queries. Dosing errors were identified for the following AEDs: carbamazepine, gabapentin, lamotrigine, levetiracetam, midazolam and topiramate. All prescriptions with dosing errors were amended prior to the AED being dispensed.
Discussion
Overall, 72.1% of the prescriptions were incorrectly or inadequately completed. This compares unfavourably with similar studies. 2, 5 Using the definition of a prescription error as described by Dean et al. 1 this review included the omission of required information detail on the prescription proforma as an error because this might still result in an ''unintentional significant reduction in the probability of treatment being timely and effective''. 1 Possible explanations for the high omission rate could include time-constraint in clinic, illegible hand-writing or the perception by the prescriber that the required information was unnecessary. Electronic prescribing has been shown in some 5, 11 but not all 9,10 studies to reduce prescribing errors. McPhillips et al.
determined whether their error rates were improved at a second site with established electronic prescription and found no significant difference in errors. 5 Although there were high numbers of incomplete or inadequate prescriptions in the current study, no patients had their medication incorrectly dispensed; this reflects the pharmacists' review of each prescription prior to the drug being dispensed.
The most commonly omitted information was the strength of medication (mg/ml or tablet strength) in 48% of prescriptions. A previous study found that the most common error was the dose but no information was provided on omitted data. 3 The clinical diagnosis on a prescription provides important information and might increase the risk of an error if the indication for a certain medication is not stated. 'Epilepsy' as a clinical diagnosis is an inadequate indication for an AED. The choice of an AED is determined by a number of factors, and most importantly by the epilepsy syndrome or by seizure type (in those children with a non-syndromic epilepsy). 12 However, an epilepsy syndrome may not be immediately identified at the time the patient's epilepsy is diagnosed and may take time to evolve. Clearly, treatment should not be delayed pending the identification of a specific epilepsy syndrome and in this situation the choice of AED will be determined by the seizure type(s). It would be difficult to confirm the most appropriate choice of AED if this information has not been recorded. Clearly, it is the clinician's responsibility to prescribe the most appropriate AED, but it might be reasonable to have the choice of drug confirmed by a clinical pharmacist. Almost two thirds of the prescribers were consultants. The NICE guidelines 13 recommend that epilepsy should be diagnosed by either a paediatric neurologist or a paediatrician with expertise in epilepsy. It is unclear whether the junior doctor sought advice from the consultant prior to writing the prescription but it would be hoped that this would have occurred in most cases. Pharmacist interventions evaluated within a Spanish paediatric population found that most had a significant impact on patient health; up to 76% of all interventions were considered to have a positive impact. 3 Approximately 17% of prescribers in the current study were contacted over prescription errors. No patients were harmed as a result of medication error and this is likely to reflect the impact of the pharmacist interventions in identifying a potential error prior to the drug being dispensed. Similar to an earlier study, 3 we were unable to classify the severity of the error and clinical importance of the intervention by the clinical pharmacists because of the lack of a validated scoring system. A robust scoring system would allow a comparison of results in different units within a hospital and also between hospitals.
Literature review
Prescription errors have focused primarily on inpatientprescribing and in three broad areas: the definition of and severity of the error; prescribing errors by clinicians and potential interventions including training and electronic prescribing; and the use of clinical pharmacists to reduce error.
Definition of prescribing error
Prevalence rates of prescribing errors range widely from 2 to 79%, which reflects the absence of a robust, widely accepted and pragmatic definition.
14 A systematic review suggested that only 43 of the 203 reviewed studies used a similar definition developed by the National Coordinating Council for Medication Error Reporting and Prevention. 15 The Council define a medication error as:
''Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. ''A clinically meaningful prescribing error occurs when, as a result of a prescribing decision or prescription writing process, there is an unintentional significant (1) reduction in the probability of treatment being timely and effective or (2) increase in the risk of harm when compared with generally accepted practice''
Using the latter definition, an error rate was identified in 1.5% or 36,200 medication orders in the UK, 16 similar to studies in the USA. 1,2 Of these, 54% were related to the dose and occurred more commonly with prescriptions written during admission rather than at discharge. 16 Prescription errors that lead to potential harm are reported to be less than 1% 17 to as high as 19.7% 18 ; it was approximately 17% of all AED prescriptions in our institution.
Scales for assessing potential harm secondary to prescribing error
Not all prescribing errors cause harm. A report of medication errors in an adult tertiary neurology centre suggested that the majority of errors (92.7%) caused no harm to patients. 19 The rate of prescribing error or omission of details within the current review was high with 12% of all prescriptions requiring intervention by a clinical pharmacist. However, we did not use a scale of potential harm, either as a risk management/improvement tool or for documentation purposes. The lack of a widely used tool for identifying potential severity of harm secondary to a prescription error reflects, in part, a lack of a consistently used definition of both prescription error and what constitutes 'harm'. [1] [2] [3] [4] [5] 8, 11, [13] [14] [15] A large systematic review of studies that used different tools to assess the scale of the severity of prescribing errors found that, of 107 studies, slightly more than half (57%) used a scale of severity. However, only two of the identified tools were reliable and validated. 20, 21 In spite of a wide range of scales, none are widely used in clinical practice. The authors emphasised the need to develop a validated and accepted scale to assess the severity of a prescribing error and to allow a comparison of errors between institutions, 22 a view shared by both Fernandez-Llamazares et al. 3 and ourselves. The identification of prescribing errors is important for both research and for clinical practice. A study of cytotoxic drugprescribing found that harm caused by a prescribing error was usually due to multiple factors. 23 Studies that have specifically addressed AED-prescribing have emphasised that the transition of patients from secondary to community or ambulatory care is a potential time for errors in drug preparation (including brand) or dose 12, 24 ; in epilepsy management, it is clearly important to maintain consistent dosing regimens and brands of medication when transferring care to optimise seizure control and avoid toxicity. 26, 29, 30 As yet, no study has specifically assessed improvements in quality of life. 27 It has been suggested that trainee pharmacists are better at identifying errors than other nurses or doctors. It has been suggested that this may reflect a different emphasis in their training compared with other professional. 31 It is standard practice in our institution for a designated clinical pharmacist to be allocated to all wards; this reduces potential prescribing errors and expedites the discharge of all patients with take-home drugs. Approximately 17% of prescribers in the current review were contacted about prescription errors most of which could potentially have led to patient harm, through under-or over-dosing or incorrect choice of AED. The fact that no patient did come to harm reflects the impact of the clinical pharmacist in the identification of the error prior to the drug being dispensed.
One study that compared prescribing errors in two groups of patients demonstrated that these were halved in the group with intervention by a clinical pharmacist. 26 This was supported by the findings of a Spanish population where of all interventions, 76% were considered to have had a positive impact. 3 The authors also used a scale of potential harm and this suggested that 49 of the 1475 pharmacist interventions were to correct a ''dosage error that could have resulted in potentially toxic concentrations''. Another study undertook a cost-benefit analysis of pharmacists and their role in preventing prescribing error 32 ; calculations were based upon a prescribing error rate of 1.5% and it was suggested that pharmacists could provide a significant economic benefit.
32
A likely criticism of pharmacists' interventions may be that their advice on specific drug or dose recommendations will be relatively rigid and based on published guidelines including the British National Formulary (BNF) and British National Formulary for Children (BNF-C) or the National Institute for Health and Clinical Excellence (NICE). This does not necessarily take account of the knowledge, specialism and clinical experience of the prescriber who may have been prescribing a drug outside the recommended doses or regime for some years without harm to the patient. However, we feel that the pharmacist has an important role in at least questioning any potentially harmful error and this includes the choice of AED, its starting or maintenance dose or dosing regimen. None of the pharmacy interventions in the current study were considered to be inappropriate and none were detrimental to patient care. The fact that only 56% of prescriptions included a legible or clear diagnosis also allowed the pharmacist to question the indication for and choice of the prescribed antiepileptic drug.
4.1.3.2.
Training and e-learning prescribing packages. It could be expected that human error is likely to be the largest source of prescribing errors. Prescribers may not be in an 'ideal situation' to fully concentrate on the task of prescribing and may be influenced by fatigue, level of experience, formalised training and concentration, particularly if the ward environment is very busy. One study that examined a large number (45,366) of 'orders' (prescriptions, laboratory tests) found no statistical correlation between the time the order was written with a doctor's single 24-h shift and either the number, or significance of, prescribing errors. The study did not take into account potential cumulative effects of medical rotas or the medical speciality. 33 A wrong dose calculation is obviously likely to lead to prescribing errors. When testing paediatric trainees under 'ideal' (i.e. examination) conditions, no correlation was found between seniority and error, although more potentially severe medication errors (specifically, a tenfold dose error) were perpetrated by first or second year junior doctors (residents). 34 The same study suggested that different healthcare professionals receive a different focus regarding prescriptions of medication; nursing staff receive more detailed training on correct drug dose calculation than equivalent medical staff. 33 Several studies have tried to evaluate, and have shown, a reduction of prescription errors following taught, self-directed or e-learning interventions. Findings are difficult to compare because studies report on different training packages, training formats and intended cohort of learners (medical/nursing and undergraduate/ postgraduate). 35 Major criticisms of these studies are that the sample sizes are small and outcome measures are based on examination-style assessments which do not typically reflect routine clinical practice. A systematic review of educational interventions found that only one tool has sufficient evidence to support its effectiveness, with six studies identified as supporting. 35 This is teaching sessions based on the 'WHO good prescribing guide' which has shown a statistically significant improvement in prescribing post intervention. [36] [37] [38] [39] [40] [41] However, the use of teaching programmes to reduce prescribing errors remains unproven, primarily because of a lack of a reliable and validated learning tool. It is worth noting that almost all studies that have evaluated teaching programmes focus on medical students or junior doctors. In the current review, high levels of error or omission of details still occurred despite most prescriptions being completed by a consultant (67.7%).
Although it could be argued that the added complexity of paediatric AED-prescribing increases the risk of prescribing errors, this would seem untenable for experienced consultants and would not explain the omission of important information on patient weight, formulation and dose regimen of the AED and indication for the drug's use.
Electronic prescribing (e-prescribing)
Electronic prescribing is regarded by many as the obvious method to reduce errors and specifically those that relate to legibility. These include the initiative, 'Safer Hospitals Safer Wards' proposed by the Department of Health and NHS England. Funds are to be made available to help adopt safe electronic record-keeping and prescriptions with integrated electronic versions. 42 Of 101 hospitals recently surveyed, 69% used e-prescribing. 42 Studies that support e-prescribing [43] [44] [45] [46] [48] [49] [50] have focused on inpatient prescriptions 41 and emphasised the main benefit of legibility. [48] [49] [50] In our institution, all outpatient prescriptions are hand-written using an A4-size proforma. Our review identified that five (1.9%) of all prescriptions included illegible doses or dose regimens and could not dispensed. An additional 10.1% also included illegible information but this did not necessitate intervention by a pharmacist. Additional reported benefits of e-prescribing include: automated prompts on any aspects of prescribing (such as interactions), limits on prescribable dosages (e.g. to reduce tenfold dose errors), and simplified medication-selection through 'dropdown' menus and recommended doses and timings of doses.
However, e-prescribing is not infallible and potential disadvantages include cost, compatibility of existing systems, computer or network failures and appropriate training. Some studies have suggested an increase in total errors 47 but a decrease in their clinical significance. 48 A systemic review of e-prescribing emphasised that while nine of the 13 studies reviewed showed a significant decrease in error rates, few studies addressed the severity of error and those that did showed decreases mostly in minor errors. 51 This may relate to drop-down lists which although designed to be quick, may, in an inattentive prescriber, result in an incorrect selection (e.g. patient, drug, dose regimen or preparation) or duplicate drug prescription. 48, 49 The most commonly identified discrepancy was one over administration instructions in a study that compared electronic prescriptions with the medications subsequently dispensed. 52 A study of a 'closed-loop prescribing and administering system' that used barcodes of inpatient prescriptions resulted in a reduced number of medication administration errors but an increase (p value <0.05) in both prescribing and dispensing times. 53 The systematic review concluded that the existing evidence behind electronic prescribing reducing error rates was 'not compelling' and that currently, support for e-prescribing is based on small scale studies. 52 Despite these potential difficulties, It is likely that e-prescribing will become the standard method of prescribing although there will always be a need for a paper back-up in the event of IT failure.
Other interventions to optimise prescribing accuracy
Limited evidence suggests that other approaches may also improve inpatient prescribing practice, including standardisation of prescription sources, 52 prescription proformas, 54 pocket tables with dosing guidelines, pocket PC-based automatic dosage calculation, 55 dedicated prescribing stations and daily feedback. 56 Studies that have evaluated the benefits of reducing prescriberdistraction or specific drug dose calculation devices have shown up to a 10% reduction in prescribing errors. 53 Some of these interventions may also be applicable for outpatient-prescribing.
Conclusion
The current study has demonstrated a high rate of prescribing errors of anti-epileptic dugs within a single institution (a large children's hospital). At least one omission was identified in over 70% of all prescriptions and one in six prescriptions required intervention by a clinical pharmacist before the drug could be dispensed. This clearly indicates a clear need to reduce prescriptions errors, a conclusion supported by the findings of other, larger studies. Prescription errors may result in significant patient harm with potential clinical and legal consequences with wider implications for the National Health Service.
The development of a robust and validated scale to score the severity of prescription errors and their clinical importance is also important for both clinical and research purposes.
The reduction of prescribing errors could be achieved using different approaches, including improved training of prescribers, the use of electronic prescribing and closer involvement within clinical teams by a clinical pharmacist.
The results of this survey have been presented to the paediatric neurology, general paediatric and pharmacy departments within the hospital; the survey will be repeated within the near future.
